Literature DB >> 27921112

[Gastroenterological diseases as triggers of chest pain].

J Labenz1, C Labenz2.   

Abstract

BACKGROUND: Non-cardiac chest pain is very common and gastroenterological diseases are one of the most important causes. The frequency distribution of the underlying causes depends on the sector of the healthcare system in which it is ascertained. In individual cases it must always be taken into consideration that detection of coronary heart disease, for example, does not exclude another origin of chest pain.
OBJECTIVE: This article provides a systematic review of gastroenterological diseases that can cause chest pain. Furthermore, a management algorithm was developed.
MATERIAL AND METHODS: This article is based on a selective search of the literature. RESULTS AND DISCUSSION: The most frequent cause is gastroesophageal reflux disease, which is also known as reflux-chest pain syndrome. If there are no clinical alarm signals, treatment is carried out with a proton pump inhibitor either as a diagnostic test or as a probatory therapy. If this initial management does not lead to satisfactory symptom control, extended diagnostics are indicated. In individual cases this concerns the detection or exclusion of a reflux disease, of motility disorders and structural damage to the esophagus as well as diseases of the upper abdominal organs, which can evoke chest pain. After exclusion of these morphologically and/or functionally defined diseases, a so-called functional chest pain is present. The essential mechanisms are altered pain processing, esophageal hypersensitivity and mental comorbidities. The treatment of functional chest pain often proves to be difficult.

Entities:  

Keywords:  Chest pain, functional; Chest pain, non-cardiac; Esophageal motility disorders; Esophagitis; Gastroesophageal reflux disease

Mesh:

Year:  2017        PMID: 27921112     DOI: 10.1007/s00108-016-0164-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  25 in total

1.  What is new in esophageal injury (infection, drug-induced, caustic, stricture, perforation)?

Authors:  Fabio Pace; Spinello Antinori; Alessandro Repici
Journal:  Curr Opin Gastroenterol       Date:  2009-07       Impact factor: 3.287

2.  [S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013].

Authors:  H Koop; K H Fuchs; J Labenz; P Lynen Jansen; H Messmann; S Miehlke; W Schepp; T G Wenzl
Journal:  Z Gastroenterol       Date:  2014-11-12       Impact factor: 2.000

3.  [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Authors:  W Fischbach; P Malfertheiner; P Lynen Jansen; W Bolten; J Bornschein; S Buderus; E Glocker; J C Hoffmann; S Koletzko; J Labenz; J Mayerle; S Miehlke; J Mössner; U Peitz; C Prinz; M Selgrad; S Suerbaum; M Venerito; M Vieth
Journal:  Z Gastroenterol       Date:  2016-04       Impact factor: 2.000

4.  Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial.

Authors:  Nigel W Flook; Paul Moayyedi; John Dent; Nicholas J Talley; Tore Persson; Björn W Karlson; Magnus Ruth
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

Review 5.  Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.

Authors:  Gregorios A Paspatis; Jean-Marc Dumonceau; Marc Barthet; Søren Meisner; Alessandro Repici; Brian P Saunders; Antonios Vezakis; Jean Michel Gonzalez; Stine Ydegaard Turino; Zacharias P Tsiamoulos; Paul Fockens; Cesare Hassan
Journal:  Endoscopy       Date:  2014-07-21       Impact factor: 10.093

6.  Oesophageal eosinophilic infiltration in patients with noncardiac chest pain.

Authors:  S R Achem; C Almansa; M Krishna; M G Heckman; H C Wolfsen; N J Talley; K R DeVault
Journal:  Aliment Pharmacol Ther       Date:  2011-04-05       Impact factor: 8.171

7.  Risk factors for non-cardiac chest pain in the community.

Authors:  J L Wise; G R Locke; A R Zinsmeister; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2005-11-15       Impact factor: 8.171

Review 8.  Review article: the current treatment of non-cardiac chest pain.

Authors:  N George; J Abdallah; C Maradey-Romero; L Gerson; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2015-11-23       Impact factor: 8.171

9.  Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study.

Authors:  D Jaspersen; M Kulig; J Labenz; A Leodolter; T Lind; W Meyer-Sabellek; M Vieth; S N Willich; D Lindner; M Stolte; P Malfertheiner
Journal:  Aliment Pharmacol Ther       Date:  2003-06-15       Impact factor: 8.171

Review 10.  The Interdisciplinary Management of Acute Chest Pain.

Authors:  Raphael R Bruno; Norbert Donner-Banzhoff; Wolfgang Söllner; Thomas Frieling; Christian Müller; Michael Christ
Journal:  Dtsch Arztebl Int       Date:  2015-11-06       Impact factor: 5.594

View more
  1 in total

Review 1.  The role of oesophageal physiological testing in the assessment of noncardiac chest pain.

Authors:  Henriette Heinrich; Rami Sweis
Journal:  Ther Adv Chronic Dis       Date:  2018-09-11       Impact factor: 5.091

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.